亚太地区组织切片市场预测至 2028 年 - COVID-19 影响和区域分析(按产品)[仪器(旋转切片机、超薄切片机、冷冻切片机、滑动切片机等)、配件和耗材以及服务]、技术(自动、半自动和手册)、应用程序(诊断和研究)和最终用户(医院、诊所、诊断实验室、数字路径实验室等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 145    |    Report Code: TIPRE00026799    |    Category: Life Sciences

Asia Pacific Tissue Sectioning Market

亚太地区组织切片市场预计将从 2021 年的 1.2529 亿美元增至 2028 年的 2.045 亿美元。预计从 2021 年到 2028 年将以 6.6% 的复合年增长率增长2028年。

机器人和自动化在医疗保健领域的日益普及以及政府对诊断研发的支持不断增加是推动这一趋势的主要因素。这个市场的增长。然而,熟练专业人员的缺乏预计将限制预测期内的市场增长。

世界各地对医疗研发活动的投资都在增加。美国、欧洲和印度政府正在积极投资研究活动,以稳定国家的整体健康状况。政府举措正在为市场参与者创造利润丰厚的机会。据 NITI Aayog 称,2021 年印度诊断行业出现了重大增长机会。诊断和病理中心也在扩大其服务范围,包括专业领域的各种服务。然而,引人注目的金融支持者正在建立中心辐射型模型,从而合并业务。

发展中国家的新兴市场为主要参与者的业务扩张提供了有吸引力的机会,导致未来几年市场大幅增长。在历史上,组织切片是基于对组织样本的粗略解剖。凭借微波处理、切割和染色自动化、显微镜检查以及载玻片图像数字化,现代组织学摆脱了原始实验室的束缚。医疗保健中的机器人技术是一种先进且即将推出的组织切片方法。机器人在组织切片中的全面实施预计将在未来几年内以所有可能的方式消除组织病理学实验室测试中产生的错误。机器人可以通过多种方式提高结果准确性,同时降低服务成本。

随着世界已转向自动化,医疗保健行业仍在致力于自动化它的服务。例如,2021 年 11 月,总部位于纽约的医疗机器人公司 Clarapath 在几轮融资中净赚 1600 万美元。该公司计划利用这笔资金开发其自动组织切片设备SectionStar,并将其推向非临床实验室市场。据称该设备基于人工智能驱动的算法来解释人体组织。 Clarapath 的SectionStar 将众多手动切割、质量控制和决策方式整合到一件装备中,在组织切片中表现更好,快速处理边缘,并降低总体成本,同时提供有关这些组织样本的丰富数据集。亚太地区组织切片市场迫在眉睫的是发达国家对机器人的日益适应。

由于 COVID-19 发病率不断上升,亚太地区国家面临着严峻的挑战。 COVID-19 大流行影响了这些国家的医疗保健系统,导致收入较 3 月份下降 50% 至 70%。然而,与其他行业不同的是,病理学和诊断行业在增长和收入方面经历了巨大的繁荣。

组织切片市场观察到了 COVID-19 的轻微积极影响随着与 COVID-19 诊断相关的病例和研究数量不断增加。例如,2020 年 7 月,《翻译医学杂志》发表了一项关于使用市售试剂在福尔马林固定石蜡包埋的组织切片中检测 SARS-CoV-2 的研究。在这项研究中,使用一组市售抗体对来自 COVID-19 患者和非 COVID-19 患者的总共 8 个尸检肺、1 个胎盘和 10 个肾活检样本进行了染色。

随着许多亚太国家开展新冠肺炎 (COVID-19) 疫苗接种活动,印度被证明是最有效、最快的疫苗接种活动。例如,印度的疫苗接种活动于1月16日启动。十个月内,接种人数突破了 10 亿卢比大关,这是该国医疗保健系统的一项成就。该地区对诊断测试和研究以获得疫苗接种结果的需求不断增加。上述实例清楚地表明了用于各种研究目的的组织切片市场的激增。

亚太组织切片市场

到 2028 年的收入和预测(百万美元)

亚太组织细分市场

产品

  • 仪器
    • 旋转切片机
    • 超薄切片机
    • 冷冻切片机
    • 滑动切片机
    • 其他
  • 配件和消耗品
  • 服务

通过

技术

  • 自动
  • 半自动
  • 手动

按应用

  • 诊断
  • 研究

最终用户

  • 医院
  • 诊所
  • 诊断实验室
  • 数字路径实验室
  • span>
  • 其他

按国家/地区

  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 韩国
  • 公司简介

    • Thermo FISHER SCIENTIFIC, INC.
    • Leica Biosystems Nussloch GmbH(丹纳赫)
    • Diapath SpA
    • Abcam Plc
    • 阿莫斯科学有限公司
    • SAKURA FINETEK EUROPE BV
    • MEDITE 医疗有限公司


    Asia Pacific Tissue Sectioning Strategic Insights

    Strategic insights for Asia Pacific Tissue Sectioning involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/asia-pacific-tissue-sectioning-market-strategic-framework.webp
    Get more information on this report

    Asia Pacific Tissue Sectioning Report Scope

    Report Attribute Details
    Market size in 2021 US$ 125.29 Million
    Market Size by 2028 US$ 204.50 Million
    Global CAGR (2021 - 2028) 6.6%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By 产品
    • 仪器
    • 配件及耗材
    • 服务
    By 技术
    • 自动
    • 半自动
    • 手动
    By 应用
    • 诊断
    • 研究
    By 最终用户
    • 医院
    • 诊所
    • 诊断实验室
    • 数字路径实验室
    Regions and Countries Covered 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
    Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC, INC.
  • Leica Biosystems Nussloch GmbH (Danaher)
  • Diapath S.p.A
  • Abcam Plc
  • Amos Scientific Pty Ltd
  • SAKURA FINETEK EUROPE B.V
  • MEDITE Medical GmbH
  • Get more information on this report

    Asia Pacific Tissue Sectioning Regional Insights

    The regional scope of Asia Pacific Tissue Sectioning refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-tissue-sectioning-market-geography.webp
    Get more information on this report

The List of Companies - Asia Pacific Tissue Sectioning Market

  1. THERMO FISHER SCIENTIFIC, INC.
  2. Leica Biosystems Nussloch GmbH (Danaher)
  3. Diapath S.p.A
  4. Abcam Plc
  5. Amos Scientific Pty Ltd
  6. SAKURA FINETEK EUROPE B.V
  7. MEDITE Medical GmbH
Frequently Asked Questions
How big is the Asia Pacific Tissue Sectioning Market?

The Asia Pacific Tissue Sectioning Market is valued at US$ 125.29 Million in 2021, it is projected to reach US$ 204.50 Million by 2028.

What is the CAGR for Asia Pacific Tissue Sectioning Market by (2021 - 2028)?

As per our report Asia Pacific Tissue Sectioning Market, the market size is valued at US$ 125.29 Million in 2021, projecting it to reach US$ 204.50 Million by 2028. This translates to a CAGR of approximately 6.6% during the forecast period.

What segments are covered in this report?

The Asia Pacific Tissue Sectioning Market report typically cover these key segments-

  • 产品 (仪器, 配件及耗材, 服务)
  • 技术 (自动, 半自动, 手动)
  • 应用 (诊断, 研究)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Tissue Sectioning Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Tissue Sectioning Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Asia Pacific Tissue Sectioning Market?

    The Asia Pacific Tissue Sectioning Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • THERMO FISHER SCIENTIFIC, INC.
  • Leica Biosystems Nussloch GmbH (Danaher)
  • Diapath S.p.A
  • Abcam Plc
  • Amos Scientific Pty Ltd
  • SAKURA FINETEK EUROPE B.V
  • MEDITE Medical GmbH
  • Who should buy this report?

    The Asia Pacific Tissue Sectioning Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Tissue Sectioning Market value chain can benefit from the information contained in a comprehensive market report.